When a patient begins chemotherapy, the fight is double one against the cancer cells, and another against the side effects that can linger long after the last ...
Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...
Your legs and feet can reveal surprising clues about your health. From swelling to numbness, discover the silent symptoms you shouldn’t ignore and what they could mean.
Interstitial Lung Disease (ILD): In the PHAROS trial, 1 patient (1%) receiving MEKTOVI with BRAFTOVI developed pneumonitis. Assess new or progressive unexplained pulmonary symptoms or findings for ...
(PRs) among 13 evaluable non-small cell lung cancer (NSCLC) patients (ORR 38%); 1 confirmed PR among 7 breast cancer patientsFavorable safety and PK profile, with encouraging activity, demonstrate a ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced landmark results demonstrating ...
A warning has been issued over 188 medical conditions which could affect your ability to drive. Failing to report certain medical conditions to the DVLA could result in a fine of up to 1,000. The DVLA ...
The ongoing CRB-701 Phase 1/2 clinical trial ( NCT06265727) is evaluating the safety, pharmacokinetics, and efficacy of CRB-701 in patients with advanced solid tumors known to be associated with high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results